Vericel (VCEL) Depreciation & Amortization (CF) (2010 - 2026)

Vericel's (VCEL) quarterly Depreciation & Amortization (CF) came in at $3.3 million in Q1 2026, up 21.63% year-on-year from $2.7 million in Q1 2025, and up 5.8% quarter-over-quarter from $3.1 million in Q4 2025.

Vericel (VCEL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Vericel has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $3.3 million for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $3.3 million, up 21.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 77.99% YoY), and the FY2025 annual result was $11.5 million, up 109.74% from the prior year.
  • Depreciation & Amortization (CF) came in at $3.3 million for Q1 2026 at Vericel, up from $3.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.3 million in Q1 2026 to a low of $873000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $1.3 million (2024), against an average of $1.7 million.
  • Across the five-year window, Depreciation & Amortization (CF) climbed 6.45% in 2023 and surged 122.02% in 2025, its largest moves.
  • Vericel's Depreciation & Amortization (CF) stood at $1.0 million in 2022, then rose by 10.59% to $1.1 million in 2023, then advanced by 28.55% to $1.5 million in 2024, then soared by 109.07% to $3.1 million in 2025, then grew by 5.8% to $3.3 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $3.3 million (Q1 2026), $3.1 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 3.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.27 Mn
Mar 31, 2026 3.27 Mn
Dec 31, 2025 3.09 Mn
Dec 31, 2025 3.09 Mn
Sep 30, 2025 2.94 Mn
Sep 30, 2025 2.94 Mn
Jun 30, 2025 2.83 Mn
Jun 30, 2025 2.83 Mn
Mar 31, 2025 2.69 Mn
Mar 31, 2025 2.69 Mn
Dec 31, 2024 1.48 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.32 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.38 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.15 Mn
Dec 31, 2023 1.15 Mn